IL2 and breast cancer: It acts as a ligand for developing effectors of native natural killer and interleukin 2-activated killer cells in the cytolytic pathway.38 In the present study, we found first evidence that oxidative phosphorylation complexes, including F1Fo ATP synthase and ETC complexes, were ectopically expressed on the PM of breast cancer cells (Figure 1).